

Company analysis: BYD
Company Analysis: BYD
Data support a balanced stance. On the positive side, 2Q sales momentum improved strongly QoQ and overseas sales reached a new record in June 2026, while Europe communications indicate accelerating registrations in selected markets. (cnevpost.com) On the negative side, the latest statutory financials (1Q 2026) show a sharp YoY contraction in net profit (-55.38%) and operating cash flow (-67.48%), indicating elevated sensitivity to pricing/mix and utilization. (www1.hkexnews.hk) With the current price in EUR unknown and near-term earnings volatility still high, HOLD is the most data-consistent recommendation until subsequent reported results confirm that the volume rebound is translating into improved margins and cash generation.
Summary
BYD Company Limited (listed in Hong Kong as 1211.HK and in Shenzhen as 002594.SZ) is a vertically integrated new-energy vehicle (NEV) and electrification platform spanning passenger EV/PHEV manufacturing, power batteries, power electronics, and related components. Its core competency is cost and cycle-time control through in-house battery technology and high internal content, which supports rapid model refreshes and price positioning across mass-market segments. In 1Q 2026, BYD reported operating revenue of RMB 150.23bn (-11.82% YoY) and net profit attributable to shareholders of RMB 4.08bn (-55.38% YoY), with operating cash flow of RMB 2.79bn (-67.48% YoY). This indicates meaningful operating deleverage versus the prior-year quarter and highlights sensitivity to volume/mix and pricing dynamics. The same filing shows total assets of RMB 902.08bn (+2.08% vs year-end) and shareholders’ equity of RMB 249.92bn (+1.48%). (www1.hkexnews.hk) Recent months’ newsflow has been mixed: sell-side commentary has emphasized expectations for a sequential rebound after a weak 1Q, with S&P Global Market Intelligence noting analysts’ expectations for recovery in volumes/earnings and citing the 1Q net income decline and volume softness. (spglobal.com) Monthly sales reporting has also pointed to improving quarterly momentum, with June 2026 data indicating 2Q NEV sales of 1,108,048 units (+58.19% QoQ; -3.24% YoY) and overseas sales reaching a new record (per CnEVPost). (cnevpost.com) In Europe, BYD’s own regional communications highlighted record 1H 2026 performance in the UK and a record June in Spain with strong plug-in registrations, supporting the narrative of accelerating brand penetration in selected markets. (bydukmedia.com) Valuation and consensus: market data aggregators and broker-consensus pages indicate a broadly positive analyst stance (e.g., “Strong Buy/Buy” consensus across multiple platforms), though targets vary by broker and methodology. (investing.com) Because the user’s “current price” is unknown and the request is “in EUR,” this analysis focuses on fundamentals and relative valuation indicators rather than a precise EUR price conversion. Outlook (short- to medium-term): the key swing factors are (1) the extent of margin recovery after 1Q deleverage, (2) sustainability of overseas volume growth and mix, and (3) competitive pricing intensity in China and Europe. The data-driven base case implied by recent sell-side commentary is sequential improvement from 2Q onward, but with elevated earnings volatility versus prior years given pricing and mix pressures. (spglobal.com)
Key Takeaways
- 1Q 2026 showed a sharp YoY earnings reset: revenue RMB 150.23bn (-11.82% YoY) and net profit RMB 4.08bn (-55.38% YoY), with operating cash flow RMB 2.79bn (-67.48% YoY). (www1.hkexnews.hk)
- Balance sheet continued to expand modestly in 1Q 2026 (total assets RMB 902.08bn; equity RMB 249.92bn), suggesting capacity to fund operations/investment, but cash generation in the quarter was weaker. (www1.hkexnews.hk)
- Sell-side and market-intelligence commentary in late May 2026 framed 1Q weakness as a trough with expectations for a 2Q rebound in volumes/earnings. (spglobal.com)
- Operational momentum improved into 2Q: reported 2Q NEV sales of 1,108,048 units (+58.19% QoQ) and record overseas sales in June 2026 (per CnEVPost). (cnevpost.com)
- Europe traction is increasingly visible in selected markets (UK 1H 2026 records; Spain June 2026 record registrations and strong H1 leadership claims in plug-ins), supporting diversification away from China-only demand. (bydukmedia.com)
Action Ideas
12–18 month accumulation thesis focused on sequential recovery and overseas mix: (a) 1Q 2026 earnings weakness is well-documented in statutory filings, creating a clearer baseline for monitoring recovery; (b) 2Q sales momentum improved materially QoQ and overseas sales hit a new record in June, which can support better utilization and mix if sustained; (c) consensus positioning across multiple platforms remains broadly positive (Strong Buy/Buy), implying continued institutional support if execution stabilizes. This action is contingent on confirming margin/earnings normalization in subsequent results versus 1Q 2026 levels.
Horizon: 18 mo.
6–12 month monitoring stance for existing holders: maintain exposure while requiring evidence that the post-1Q rebound translates into improved profitability and cash generation. The data show improving 2Q sales momentum and positive Europe headlines, but 1Q financial deterioration was substantial. A HOLD is appropriate if the investor requires confirmation via the next reported financials that margins and operating cash flow are recovering from 1Q 2026 levels.
Horizon: 9 mo.
3–6 month risk-reduction thesis for investors with low tolerance for earnings drawdowns: 1Q 2026 demonstrated a large YoY profit decline and weaker operating cash flow, which can lead to short-term valuation compression if subsequent quarters do not show clear margin recovery. This action prioritizes capital preservation until there is confirmed improvement in reported profitability and cash generation.
Horizon: 6 mo.
Contrarian Insights
- • Consensus appears broadly constructive (Strong Buy/Buy across multiple platforms), but the statutory 1Q 2026 filing shows a pronounced earnings and operating cash flow contraction; a contrarian view is that the market may be underpricing the duration of margin normalization after operating deleverage. (www1.hkexnews.hk)
- • Europe momentum headlines (UK and Spain records) can lead to extrapolation; a contrarian framing is that near-term Europe growth may not be sufficient to offset profitability pressure if China pricing remains intense, so investors should track profit/cash conversion rather than registrations alone. (bydukmedia.com)
Sources (8)
- https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0428/2026042803001.pdf
- https://www.spglobal.com/market-intelligence/en/news-insights/research/2026/05/byd-set-for-q2-rebound-as-analysts-expect-volumes-and-earnings-to-recover
- https://cnevpost.com/2026/07/01/byd-jun-2026-sales/
- https://bydukmedia.com/en/news-articles/byd-continues-to-break-uk-sales-records-in-the-first-half-of-2026.html
- https://www.byd.com/es-es/news-list/byd-record-matriculaciones-junio-2026
- https://www.etnet.com.hk/www/eng/stocks/realtime/quote_profit.php?code=1211
- https://www.investing.com/equities/byd-co.-consensus-estimates
- https://markets.ft.markitdigital.com/data/equities/tearsheet/forecasts?s=1211%3AHKG
BYD at Synthszr
- WWDC26 Special: Apple präsentiert neues AI-Siri und verzweifelt an Europa09 juin 2026
- AI Deployment Companies sollen das Adaptionsproblem von Enterprise-KI lösen12 mai 2026
- Schmutzige Wäsche vor Gericht und Anthropic will Strompreiserhöhungen für Verbraucher kompensieren08 mai 2026
- Tim Cook übergibt an den KI-Skeptiker John Ternus21 avr. 2026
- Claude kopiert immer mehr OpenClaw und China kopiert längst nicht mehr24 mars 2026
- Metas' Smart Glasses sehen alles. Wirklich alles.10 mars 2026